![John Orloff](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Orloff
Nessuna posizione attualmente
Patrimonio netto: - $ in data 30/06/2026
Profilo
Attualmente, John J. Orloff è Executive VP, Head-Research & Development presso Alexion Pharmaceuticals, Inc. In passato ha ricoperto la posizione di direttore presso Novelion Therapeutics, Inc., vicepresidente esecutivo e responsabile della ricerca presso Aegerion Pharmaceuticals, Inc., direttore scientifico, EVP, Global Head-R&D presso Baxalta, Inc., vicepresidente, Global Head-Research & Development presso Baxter BioScience Corp. e Chief Medical Officer & Senior Vice President di Novartis Pharma AG. Il dottor Orloff ha conseguito una laurea presso il Dartmouth College e un dottorato presso l'Università del Vermont College of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
-.--% | 15/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Posizioni attive di John Orloff
| Società | Posizione | Inizio |
|---|---|---|
Agent Capital LLC
 Agent Capital LLC Investment ManagersFinance Agent Capital invests in companies located in the United States. The firm targets companies operating in the fields of therapeutics sectors and industries. It provides financing for seed, early, late stage, crossover and PIPE stage requirements. The firm acts as a lead investor and also makes co-investments. | Investitore di Private Equity | 01/10/2021 |
Zenas Pharma, Inc.
 Zenas Pharma, Inc. BiotechnologyHealth Technology Develops and markets immunology based therapies for patients | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di John Orloff
| Società | Posizione | Fine |
|---|---|---|
| BENEVOLENTAI S.A. | Direttore/Membro del Consiglio | 16/10/2024 |
BenevolentAI Ltd.
 BenevolentAI Ltd. Packaged SoftwareTechnology Services Operates as a AI-enabled drug discovery company | Direttore/Membro del Consiglio | 01/10/2024 |
| ALEXION PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 21/07/2021 |
| NOVELION THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 01/07/2017 |
| BAXALTA INC | Direttore Tecnico/Scientifico/R&S | 01/06/2016 |
Formazione di John Orloff
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
68
Relazioni di 1° grado
13
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 13 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
Baxalta, Inc.
 Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baxter BioScience Corp.
 Baxter BioScience Corp. BiotechnologyHealth Technology Provides biopharmaceutical and vaccines services | Health Technology |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
University of Vermont College of Medicine
 University of Vermont College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets rare disease products, metreleptin and lomitapide | Health Technology |
BenevolentAI Ltd.
BenevolentAI Ltd. Packaged SoftwareTechnology Services Operates as a AI-enabled drug discovery company | Technology Services |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital invests in companies located in the United States. The firm targets companies operating in the fields of therapeutics sectors and industries. It provides financing for seed, early, late stage, crossover and PIPE stage requirements. The firm acts as a lead investor and also makes co-investments. | Finance |
BenevolentAI SA
 BenevolentAI SA Packaged SoftwareTechnology Services Develops AI drug discovery platform to accelerate biopharma drug discovery | Technology Services |
Zenas Pharma, Inc.
Zenas Pharma, Inc. BiotechnologyHealth Technology Develops and markets immunology based therapies for patients | Health Technology |
